Journal of Clinical Epidemiology
Volume 55, Issue 2 , Pages 157-163 , February 2002

Incidence of serious upper gastrointestinal bleeding/perforation in the general population: Review of epidemiologic studies

  • Sonia Hernández-Dı́az

      Affiliations

    • Slone Epidemiology Unit, Boston University School of Public Health, Boston, MA, USA
    • ,
  • Luis Alberto Garcı́a Rodrı́guez

      Affiliations

    • Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante, 28-2, 28004 Madrid, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34-91-5313404; fax: +34-91-5312871. E-mail address:(L.A.G. Rodriguez)

Received 29 June 2000 ,Revised 22 August 2001 ,Accepted 30 August 2001.

References 

  1. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;115:787–796
  2. Hernández-Dı́az S, Garcı́a-Rodrı́guez LA. Overview of epidemiological studies published in the nineties on the association between non-steroidal anti-inflammatory drugs and upper gastrointestinal bleed/perforation. Arch Intern Med. 2000;in press:
  3. Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol. 1998;51:1357–1365
  4. Smalley WE, Griffin MR. The risk and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterol Clin North Am. 1996;25:373–396
  5. Takkouche B, Cadarso-Suárez C, Spiegelman D. An evaluation of old and new tests of heterogeneity in meta-analysis in epidemiologic research. Am J Epidemiol. 1999;150:206–215
  6. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  7. Greenland S. Invited commentary (a critical look at some popular meta-analytic methods). Am J Epidemiol. 1994;140:290–296
  8. Cooper H, Hedges LV. The handbook of research synthesis. New York: Russel Sage Foundation; 1994;
  9. Kurata JH, Honda GD, Frankl H. The incidence of duodenal and gastric ulcers in a large Health Maintenance Organization. Am J Public Health. 1985;75:625–629
  10. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;462–4.
  11. Armstrong CP, Blower A. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987;28:527–532
  12. Katschinski B, Logan R, Davies J, Langman M. Audit of mortality in upper gastrointestinal bleeding. Postgrad Med J. 1989;65:913–917
  13. Laporte J-R, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal antiinflammatory drugs. Lancet. 1991;337:85–89
  14. Henry D, Robertson J. Nonsteroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales. Gastroenterology. 1993;104:1083–1091
  15. Henry D, Dobson A, Truner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 1993;105:1078–1088
  16. Langman M, Weil J, Wainwright P, et al.  Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:1075–1078
  17. Blower A, Brooks A, Fenn G, et al.  Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Alimen Pharm-acol Ther. 1997;11:283–291
  18. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy (incidence and risk factor models). Am J Med. 1991;91:213–222
  19. Voskuyl AE, Van de Laar MAFJ, Moens HJB, Van der Korst JK. Extra-articular manifestations of rheumatoid arthritis (risk factors for serious gastrointestinal events). Ann Rheumat Dis. 1993;52:771–775
  20. Matteson EL, Yachyshyn V, Yachyshyn J, O'Fallon WM. Trends in hospitalization for gastrointestinal bleeding among patients with rheumatoid arthritis in Rochester, Minnesota, 1950–1991. J Rheumatol. 1995;22:1471–1477
  21. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol. 1999;26:18–24
  22. Wolfe F, Hawley DJ. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis (a prospective 13 year study of 2131 patients). J Rheumatol. 2000;27:1668–1673
  23. Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986;489–92.
  24. Schoon I-M, Mellstrom D, Oden A, Ytterberg B-O. Incidence of peptic ulcer disease in Gothenburg, 1985. Br Med J. 1989;299:1131–1134
  25. Ohmann C, Thon K, Hengels K-J, Imhof M. Incidence and pattern of peptic ulcer bleeding in a defined geographical area. Scand J Gastroenterol. 1992;27:571–581
  26. McIntosh J, Byth K, Tsang N, Berman K, Holliday FM, Piper DW. Trends in peptic ulcer mortality in Sydney from 1971 to 1987. J Clin Gastroenterol. 1993;16:346–353
  27. Garcı́a Rodrı́guez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:769–772
  28. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage (a population-based study). Am J Gastroenterol. 1995;90:206–210
  29. Garcı́a Rodrı́guez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med. 1998;158:33–39
  30. CDCs Statistics N, CfH . National Hospital Discharge Survey (Annual Summary, 1998. Vital and Health Statistics. Vol. 13). Hyattsville: U.S. Department of Health and Human Services; 2000;
  31. Andersen IB, Jorgensen T, Bonnevie O, Gronbaek M, Sorensen TI. Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers (a population based cohort study). Epidemiology. 2000;11:434–439
  32. Paspatis G, Matrella E, Kapsoriatakis A, et al.  An epidemiological study of acute upper gastrointestinal bleeding in Create, Greece. Eur J Gastroenterol Hepatol. 2000;12:1215–1220
  33. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114:257–263
  34. Beardon PH, Brown SV, McDevitt DG. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs (a controlled study using record linkage in Tayside). Q J Med. 1989;71:497–505
  35. Carson JL, Strom BL, Morse ML, et al.  The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1987;147:1054–1059
  36. McMahon A, Evans J, White G, et al.  A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation. J Clin Epidemiol. 1997;50:351–356
  37. MacDonald T, Morant S, Robinson G, et al.  Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure (cohort study). Br Med J. 1997;315:1333–1337
  38. Garcı́a Rodrı́guez LA, Walker AM, Pérez Gutthann S. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatch-ewan (a cohort study). Epidemiology. 1992;3:337–342
  39. Pérez-Gutthann S, Garcı́a Rodrı́guez LA, Raiford DS. Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology. 1997;8:18–24
  40. Jick S, Perera D, Walker A, Jick H. Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet. 1987;2:380–382
  41. Beard K, Walker AM, Perera DR, Jick H. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med. 1987;147:1621–1623
  42. Lanza LL, Walker AM, Bortnichack EA, Dreyer NA. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study. Arch Intern Med. 1995;155:1371–1377
  43. Carson J, Strom B, Soper K, West S, Morse M. The association of non-steroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med. 1987;147:85–88
  44. Bloom BS. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1989;149:1019–1022
  45. Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol. 1995;141:539–545
  46. Guess H, West R, Strand L, et al.  Fatal upper gastrointestinal hemorrage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol. 1988;41:35–45
  47. Hallas J, Lauritsen J, Dalsgard Villadsen H, Freng Gram L. Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol. 1995;30:438–444
  48. Menniti-Ippolito F, Maggini M, Raschetti R, Da Cas R, Traversa G, Walker AM. Ketorolac use in outpatients and gastrointestinal hospitalization (a comparison with other non-steroidal anti-inflammatory drugs in Italy). Eur J Clin Pharmacol. 1998;54:393–397
  49. Sorensen TK, Malinow MR, Williams MA, King IB, Luthy DA. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest. 1999;48:98–103
  50. Ulcickas YM, Rothman K, Johnson C, et al.  Using prescription claims for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Safety. 2000;9:S37
  51. Svanes C, Lie RT, Kvale G, Svanes K, Soreide O. Incidence of perforated ulcer in Western Norway, 1935–1990 (cohort- or period-dependent time trends). Am J Epidemiol. 1995;141:836–844
  52. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barret's esophagus?. Gastroenterology. 2000;119:333–338

PII: S0895-4356(01)00461-9

Journal of Clinical Epidemiology
Volume 55, Issue 2 , Pages 157-163 , February 2002

Article Tools

* Image Usage & Resolution